377 related articles for article (PubMed ID: 29540834)
1. Controlling the master-upstream regulation of the tumor suppressor LKB1.
Kullmann L; Krahn MP
Oncogene; 2018 Jun; 37(23):3045-3057. PubMed ID: 29540834
[TBL] [Abstract][Full Text] [Related]
2. Posttranslational regulation of liver kinase B1 in human cancer.
Hu L; Liu M; Tang B; Li Q; Pan BS; Xu C; Lin HK
J Biol Chem; 2023 Apr; 299(4):104570. PubMed ID: 36870679
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M
Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014
[TBL] [Abstract][Full Text] [Related]
4. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
Hawley SA; Boudeau J; Reid JL; Mustard KJ; Udd L; Mäkelä TP; Alessi DR; Hardie DG
J Biol; 2003; 2(4):28. PubMed ID: 14511394
[TBL] [Abstract][Full Text] [Related]
5. Role of the LKB1/AMPK pathway in tumor invasion and metastasis of cancer cells (Review).
Li N; Huang D; Lu N; Luo L
Oncol Rep; 2015 Dec; 34(6):2821-6. PubMed ID: 26398719
[TBL] [Abstract][Full Text] [Related]
6. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.
Zhang Y; Meng Q; Sun Q; Xu ZX; Zhou H; Wang Y
Mol Metab; 2021 Feb; 44():101131. PubMed ID: 33278637
[TBL] [Abstract][Full Text] [Related]
7. The molecular mechanisms that underlie the tumor suppressor function of LKB1.
Fan D; Ma C; Zhang H
Acta Biochim Biophys Sin (Shanghai); 2009 Feb; 41(2):97-107. PubMed ID: 19204826
[TBL] [Abstract][Full Text] [Related]
8. LKB1 mutations frequently detected in mucinous bronchioloalveolar carcinoma.
Osoegawa A; Kometani T; Nosaki K; Ondo K; Hamatake M; Hirai F; Seto T; Sugio K; Ichinose Y
Jpn J Clin Oncol; 2011 Sep; 41(9):1132-7. PubMed ID: 21816872
[TBL] [Abstract][Full Text] [Related]
9. A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome.
Sanchez-Cespedes M
Oncogene; 2007 Dec; 26(57):7825-32. PubMed ID: 17599048
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth.
Sapkota GP; Kieloch A; Lizcano JM; Lain S; Arthur JS; Williams MR; Morrice N; Deak M; Alessi DR
J Biol Chem; 2001 Jun; 276(22):19469-82. PubMed ID: 11297520
[TBL] [Abstract][Full Text] [Related]
11. LKB1 mutation in large cell carcinoma of the lung.
Zhong D; Guo L; de Aguirre I; Liu X; Lamb N; Sun SY; Gal AA; Vertino PM; Zhou W
Lung Cancer; 2006 Sep; 53(3):285-94. PubMed ID: 16822578
[TBL] [Abstract][Full Text] [Related]
12. LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo.
Collins SP; Reoma JL; Gamm DM; Uhler MD
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):673-80. PubMed ID: 10642527
[TBL] [Abstract][Full Text] [Related]
13. The LKB1 tumor suppressor kinase in human disease.
Katajisto P; Vallenius T; Vaahtomeri K; Ekman N; Udd L; Tiainen M; Mäkelä TP
Biochim Biophys Acta; 2007 Jan; 1775(1):63-75. PubMed ID: 17010524
[TBL] [Abstract][Full Text] [Related]
14. Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling.
Lin-Marq N; Borel C; Antonarakis SE
Mol Genet Genomics; 2005 Apr; 273(2):184-96. PubMed ID: 15731909
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma.
Guldberg P; thor Straten P; Ahrenkiel V; Seremet T; Kirkin AF; Zeuthen J
Oncogene; 1999 Mar; 18(9):1777-80. PubMed ID: 10208439
[TBL] [Abstract][Full Text] [Related]
16. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism.
Jansen M; Ten Klooster JP; Offerhaus GJ; Clevers H
Physiol Rev; 2009 Jul; 89(3):777-98. PubMed ID: 19584313
[TBL] [Abstract][Full Text] [Related]
17. The LKB1 tumor suppressor negatively regulates mTOR signaling.
Shaw RJ; Bardeesy N; Manning BD; Lopez L; Kosmatka M; DePinho RA; Cantley LC
Cancer Cell; 2004 Jul; 6(1):91-9. PubMed ID: 15261145
[TBL] [Abstract][Full Text] [Related]
18. Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37.
Nony P; Gaude H; Rossel M; Fournier L; Rouault JP; Billaud M
Oncogene; 2003 Dec; 22(57):9165-75. PubMed ID: 14668798
[TBL] [Abstract][Full Text] [Related]
19. LKB1, a protein kinase regulating cell proliferation and polarity.
Boudeau J; Sapkota G; Alessi DR
FEBS Lett; 2003 Jul; 546(1):159-65. PubMed ID: 12829253
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas.
Rowan A; Bataille V; MacKie R; Healy E; Bicknell D; Bodmer W; Tomlinson I
J Invest Dermatol; 1999 Apr; 112(4):509-11. PubMed ID: 10201537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
